XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.1
INVESTMENT IN, AND NOTE RECEIVABLE FROM MELT PHARMACEUTICALS, INC. - RELATED PARTY TRANSACTIONS (Tables)
 3 Months Ended
Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
SCHEDULE OF CONDENSED INCOME STATEMENT

The unaudited condensed results of operations information of Melt is summarized below:

 

   2022   2021 
   For the Three Months Ended
March 31,		 
   2022   2021 
Revenues, net  $-   $- 
Loss from operations   (3,337,000)   (1,099,000)
Net loss  $(3,337,000)  $(1,099,000)
SCHEDULE OF CONDENSED BALANCE SHEET

The unaudited condensed balance sheet information of Melt is summarized below:

 

   At March 31,   At December 31, 
   2022   2021 
Current assets  $9,025,000   $11,278,000 
Non-current assets   360,000    - 
Total assets  $9,385,000   $11,278,000 
           
Total liabilities  $17,313,000   $15,732,000 
Total preferred stock and stockholders’ deficit   (7,928,000)   (4,454,000)
Total liabilities and stockholders’ deficit  $9,385,000   $11,278,000